These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33936169)

  • 1. Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions.
    Li Y; Deshpande P; Hertzman RJ; Palubinsky AM; Gibson A; Phillips EJ
    Front Genet; 2021; 12():641905. PubMed ID: 33936169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity.
    Deshpande P; Li Y; Thorne M; Palubinsky AM; Phillips EJ; Gibson A
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1689-1700. PubMed ID: 35526777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review-An EAACI position paper.
    Oussalah A; Yip V; Mayorga C; Blanca M; Barbaud A; Nakonechna A; Cernadas J; Gotua M; Brockow K; Caubet JC; Bircher A; Atanaskovic-Markovic M; Demoly P; Kase-Tanno L; Terreehorst I; Laguna JJ; Romano A; Guéant JL; Pirmohamed M;
    Allergy; 2020 May; 75(5):1069-1098. PubMed ID: 31899808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Mechanisms of Drug Hypersensitivity.
    Meng X; Ariza A; Waddington J; Park K; Naisbitt D
    Curr Pharm Des; 2016; 22(45):6734-6747. PubMed ID: 27697025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.
    Deshpande P; Hertzman RJ; Palubinsky AM; Giles JB; Karnes JH; Gibson A; Phillips EJ
    Clin Pharmacol Ther; 2021 Sep; 110(3):607-615. PubMed ID: 34143437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules.
    Puig M; Norcross MA
    Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):279-286. PubMed ID: 37284777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the Pathomechanisms of Delayed Drug Hypersensitivity.
    Wang CW; Divito SJ; Chung WH; Hung SI
    Immunol Allergy Clin North Am; 2022 May; 42(2):357-373. PubMed ID: 35469623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis.
    Hanson AL; ; Vukcevic D; Leslie S; Harris J; Lê Cao KA; Kenna TJ; Brown MA
    PLoS Genet; 2020 Aug; 16(8):e1008906. PubMed ID: 32804949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Concepts for Drug Hypersensitivity Based on the Use of Long-Time Scale Molecular Dynamic Simulation.
    Murai T; Kawashita N; Tian YS; Takagi T
    J Pharm (Cairo); 2016; 2016():9520361. PubMed ID: 27999707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
    Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
    Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs.
    Wung CH; Wang CW; Lai KC; Chen CB; Chen WT; Hung SI; Chung WH;
    Front Pharmacol; 2023; 14():1183491. PubMed ID: 37180708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug hapten-specific T-cell activation: Current status and unanswered questions.
    Adair K; Meng X; Naisbitt DJ
    Proteomics; 2021 Sep; 21(17-18):e2000267. PubMed ID: 33651918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying the immune interactions underlying HLA class I disease associations.
    Debebe BJ; Boelen L; Lee JC; ; Thio CL; Astemborski J; Kirk G; Khakoo SI; Donfield SM; Goedert JJ; Asquith B
    Elife; 2020 Apr; 9():. PubMed ID: 32238263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Update on the Immunological, Metabolic and Genetic Mechanisms in Drug Hypersensitivity Reactions.
    Mayorga C; Montañez MI; Jurado-Escobar R; Gil-Ocaña V; Cornejo-García JA
    Curr Pharm Des; 2019; 25(36):3813-3828. PubMed ID: 31692430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.
    D'Amico S; D'Alicandro V; Compagnone M; Tempora P; Guida G; Romania P; Lucarini V; Melaiu O; Falco M; Algeri M; Pende D; Cifaldi L; Fruci D
    Front Immunol; 2021; 12():778103. PubMed ID: 34917091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA Allele-Restricted Immune-Mediated Adverse Drug Reactions: Framework for Genetic Prediction.
    Jaruthamsophon K; Thomson PJ; Sukasem C; Naisbitt DJ; Pirmohamed M
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():509-529. PubMed ID: 34516290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
    Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
    Front Immunol; 2022; 13():922252. PubMed ID: 35911762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte transformation test and cytokine detection assays: Determination of read out parameters for delayed-type drug hypersensitivity reactions.
    Srinoulprasert Y
    J Immunol Methods; 2021 Sep; 496():113098. PubMed ID: 34216607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic testing for prevention of severe drug-induced skin rash.
    Alfirevic A; Pirmohamed M; Marinovic B; Harcourt-Smith L; Jorgensen AL; Cooper TE
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD010891. PubMed ID: 31314143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.